Traders should monitor for follow-on orders from other states and track progress toward Medicare coverage, which could significantly expand the total addressable market. The 225% YoY growth in state-funded tests suggests accelerating public sector adoption, potentially de-risking commercial scaling.
Price Chart
Executive Summary
20/20 Biolabs announced that 18 Maryland fire departments will receive over $520,000 in state funding to administer its OneTest™ multi-cancer early detection blood test to more than 1,400 firefighters. This represents a 225% increase in state-funded tests compared to last year, highlighting growing public sector validation and potential for broader Medicare reimbursement starting in 2028.
Key Financial Metrics
Key Facts
- Maryland Department of Health awarded over $520,000 to 18 fire departments to procure 20/20 Biolabs' OneTest™ MCED blood test
- Testing expected to cover over 1,400 firefighters in April or May 2026
- Represents a ~225% increase in state-funded OneTest administrations compared to 2025
- Company has now tested at least 20,000 firefighters nationwide, building real-world evidence for FDA and CMS engagement
- Medicare coverage pathway for MCED tests established by law, effective 2028; company plans to seek coverage
Financial Impact
$520,000 in direct contract value from state grant funding
Risk Factors
- Revenue from this contract is relatively small ($520K) and one-time; not immediately transformative for an $18M market cap company
- Future Medicare reimbursement is not guaranteed and may involve lengthy regulatory processes
- Company remains early-stage with limited commercial scale outside of niche firefighter programs
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3263759 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | DEFA14A | $0.2507 | awaiting T+5 | — | $0.2304 (−8.10%) |
Oct 21, 2026 5d ago | DEF 14A | $0.2507 | awaiting T+5 | — | $0.2304 (−8.10%) |
Aug 17, 2026 10w ago | 8-K | $0.5200 $0.5282 | ▲ +1.58% | ▲ +1.78% | $0.2304 (−55.69%) |
Aug 17, 2026 10w ago | Press Release | $0.5503 $0.5182 | ▼ −5.83% | ▼ −4.64% | $0.2304 (−58.13%) |
Aug 5, 2026 11w ago | 8-K | $0.4413 $0.4610 | ▲ +4.46% | ▲ +4.11% | $0.2304 (−47.79%) |
Jul 1, 2026 16w ago | 8-K | $0.6095 $0.5851 | ▼ −4.00% | ▼ −4.26% | $0.2304 (−62.20%) |
Jun 23, 2026 17w ago | DEFA14A | $0.5669 $0.6095 | ▼ −7.51% | ▼ −5.81% | $0.2304 (+59.36%) |
May 26, 2026 21w ago | 8-K | $0.9700 $0.8400 | ▼ −13.40% | ▼ −13.87% | $0.2304 (−76.25%) |
May 20, 2026 22w ago | 8-K | $1.21 $0.9500 | ▲ +21.49% | ▲ +23.09% | $0.2304 (+80.96%) |
May 20, 2026 22w ago | Press Release | $1.21 $0.9500 | ▲ +21.49% | ▲ +23.09% | $0.2304 (+80.96%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers